06Dec 2023
Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer

Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer

The HERO study compared health-related quality of life (HRQOL) between relugolix and leuprolide in advanced prostate cancer patients. With 934 participants, HRQOL was assessed using the EORTC Quality of Life Questionnaire. During treatment, no significant differences were observed. In the testosterone recovery phase, relugolix showed lower hormonal treatment–related symptom scores, indicating a potentially lower burden of symptoms compared to leuprolide. This supports relugolix as an oral option for androgen deprivation therapy with similar HRQOL to leuprolide but potentially faster testosterone recovery.

  • #urology

Like

Save

Share